Impact of the M184V/I Mutation on the efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV treatment-experienced patients
ContributorsOlearo, Flamina; Nguyen, Huyen Tran; Bonnet, Fabrice Henri Georges; Yerly Ferrillo, Sabine; Wandeler, Gilles; Stoeckle, Marcel; Cavassini, Matthias; Scherrer, Alexandra; Costagliola, Dominique; Schmid, Patrick; Günthard, Huldrych F; Bernasconi, Enos; Boeni, Jürg; D'arminio Monforte, Antonella; Zazzi, Maurizio; Rossetti, Barbara; Neau, Didier; Bellecave, Pantxika; Rijnders, Bart; Reiss, Peter; Wit, Ferdinand; Kouyos, Roger; Calmy, Alexandra
Published inOpen Forum Infectious Diseases, vol. 6, no. 10
Errata
- Corrigendum: surname of a co-author, Dominique Costagliola, was misspelled
- DOI : 10.1093/ofid/ofz500
- PMID : 31832485
Publication date2019
Abstract
Keywords
- ABC/3TC/DTG
- M184V/I
- Treatment-experienced patients
- Virological failure
Affiliation
Research group
Funding
- Swiss National Science Foundation - #177499
- Swiss National Science Foundation - #BSSGI0_155851
Citation (ISO format)
OLEARO, Flamina et al. Impact of the M184V/I Mutation on the efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV treatment-experienced patients. In: Open Forum Infectious Diseases, 2019, vol. 6, n° 10. doi: 10.1093/ofid/ofz330
Main files (1)
Article (Published version)
Secondary files (1)
Updates (1)
Corrigendum
Identifiers
- PID : unige:145511
- DOI : 10.1093/ofid/ofz330
- PMID : 31660328
Commercial URLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778427/
ISSN of the journal2328-8957
